期刊文献+

豫西地区女性宫颈病变HPV感染分子流行病学探讨 被引量:6

Molecular Epidemiological Study of Human Papillomavirus Infection Among Cervicitis Patients in Yuxi Region
原文传递
导出
摘要 目的探讨人乳头瘤病毒(Human papillomavirus,HPV)21种基因型在豫西地区女性宫颈病变中的分子流行病学特点。方法对豫西地区因宫颈病变或可疑HPV感染就诊的1540位女性进行HPV基因分型检测,共21种基因型,比较不同基因型的流行病学特点。结果本组资料中总的HPV感染比例为31.8%(489/1540),共检出21种基因亚型,高危型占35.13%,低危型占5.39%,单一感染占23.25%,双重感染或多重感染占8.51%,高危型最常见类型为HPV16、58、31,低危型最常见类型为HPV6、11。不同年龄段HPV感染率,最高为31-40岁组,占45.4%,其次为21-30岁组,占30.6%。结论本研究提供了21种HPV基因型在豫西地区的分子流行病学资料,对该地区疫苗开发、应用具有重要价值,为临床防治宫颈癌提供可靠的科学依据。 Objective To explore the molecular epidemiological characteristics of 21 genotypes of human papillomavirus(HPV)in Yuxi region.Methods The HPV types were determined among 1,540 women who were suspected to be suffering from HPV infection or cervix lesion in Yuxi Region.The molecular epidemiological characteristics of 21 HPV types were compared.Results The total positive rate of HPV was 31.8%(489/1,540).21 isoforms were checked out in these women,high-risk form accounted for 35.13%,low-risk form 5.39%,single isoform 23.25%,and double-or multi-isoforms 8.51%.HPV16,58,and 31 were mostly seen in high-risk form and HPV6 and 11 were mostly seen in low-risk form.The positive rate of HPV of the age group of 30~40 years was the highest(45.5%),followed by the age group of 21~30 years(30.6%).Conclusions This article offers molecular epidemiological characteristics of 21 genotypes of HPV and provides the reliable and scientific evidence for prevention and treatment of cervical cancer in Yuxi Region.And it is of great value to develop and apply HPV vaccine in this region.
出处 《实用预防医学》 CAS 2010年第8期1505-1506,共2页 Practical Preventive Medicine
关键词 HPV 基因型 高危型 宫颈病变 HPV Genotype High-risk form Cervix lesion
  • 相关文献

参考文献6

  • 1Division of STD Prevention. Prevention of genital HPV infection and sequelae:Report of an external consultants' meeting[R]. Centers for Disease Control and Prevention, 1999.
  • 2D' Souza G, Kreimer AR, Viscidi R, et al. Case - control study of human papillomavirus and oropharyngeal cancer[J]. New England Journal of Medicine, 2007,356 : 1944 - 1956.
  • 3潘凌亚.HPV感染与宫颈癌前病变[J].基础医学与临床,2006,26(12):1296-1301. 被引量:26
  • 4Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India[J]. The New England Journal of Medicine, 2009,360(14) : 1385 - 1394.
  • 5唐礼榕,张志毅.HPV-DNA检测在宫颈病变诊断中的价值[J].中国癌症杂志,2006,16(3):217-219. 被引量:33
  • 6Meijer CJ, Berkhof J, Castle PE, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older[J] .2009, 124(3):516- 520.

二级参考文献42

  • 1Pankin DM,Pisani P,Ferlay J.Estimates of the worldwide incidence of 25 major cancers in 1990[J].Int J Cancer,1999,80(6):827-841.
  • 2Tjalma WA,Arbyn M,Paavonen J,et al.Prophylactic human papillomavirus vaccines:the beginning of the end of cervical cancer[J].Int J Gynecol cancer,2004,14(5):756-761.
  • 3Rohan TE,Burk RD,Franco EL.Toward a reduction of the global burden of cervical cancer[J].Am J Obstet Gynecol,2003,189(4 Supple):S37-39.
  • 4Cronje HS.Screening for cervical cancer in developing countries[J].Int J Gynaecol Obstet,2004,84(2):101-108.
  • 5Saslow D,Runowicz CD,Solomon D,et al.American Cancer Society guideline for the early detection of cervical neoplasia and cancer[J].CA Cancer J Clin,2002,52(6):342-362.
  • 6Pete I,Boszep TV.The value of colposcopy in screening cervical carcinoma[J].Eur J Gynecol Oncol,1998,19(2):120-122.
  • 7Richart RM. Cervical intraepithelial neoplasia: a review[M]//Sommers SC. Pathology Annual. New York: Appleton- Century- Crofts, 1973:301 -328.
  • 8Koutsky LA, Kiviat NB. C, enital human papillomavirus [M]//K Holmes, P Mardh, P Sparling, et al. Sexually Transmitted Diseases. 3rd ed. New York: McGraw- Hill,1999:347 - 359.
  • 9Wright TC Jr, Denny L, Kuhn L, et al. HPV DNA testing of self- collected vaginal samples compared with cytologic screening to detect cervical cancer[J].JAMA, 2000, 283(1) :81 -86.
  • 10Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia. Using human papillomavirus DNA testing for equivocal papanicolaou results[J]. JAMA, 1999, 281:1605 - 1610.

共引文献57

同被引文献49

  • 1黄庆,府伟灵,周玉,张雪,黄君富,陈斌.基因芯片对人乳头瘤病毒的快速检测和分型[J].中华医院感染学杂志,2005,15(4):476-478. 被引量:50
  • 2刘敏,王传新,邓小梅,王立水,张建,李伟,郑桂喜,王金凤.应用液相基因芯片技术筛查山东地区高危人群人乳头瘤病毒基因型[J].中华流行病学杂志,2007,28(5):487-490. 被引量:36
  • 3BULK S, BERKHOF J, BULKMANS N W, et al. Preferential risk of HPV16 for squamous celt carcinoma and of HPV18 for adenocaicinoma of the cervix compared to women with normal cytology in the Northern- lands[ J]. Br J Cancer,2006,94( 1 ) : 171-175.
  • 4AULT KA, GIULIANO A R, EDWARDS R P, et al. A phase I study to evaluate a human papillomavims(HPV) type 18 L1 VLP vaccine[ J]. Vaccine ,2004,22 ( 23-24 ) :3004-3007.
  • 5ZUR HAUSEN H. Cervical carcinoma and human papillomavims: on the road to preventing a major human cancer [ J ]. J Natl Cancer Inst, 2001,93 (4) :252-253.
  • 6MUNOZ N, BOSCH F X, DE SANJOSE S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer [ J]. N Engl J Med ,2003,348(6) :518-527.
  • 7LEE S A,KANG D,SEO S S,et al. Multiple HPV infection in cervical cancer screened by HPV DNAChip [ J ]. Cancer Lett, 2003,198 ( 2 ) : 187-192.
  • 8MUNOZ N,BOSCH F X,CASTELLSAGUE X,et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective [ J ]. Int J Cancer,2004,111 ( 2 ) :278-285.
  • 9RALSTON HOWE E, LI Z, MCGLENNEN R C, et al. Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening [ J].Am J Obsted Gynecol, 2009, 200 ( 3 ) : 245 e1- e7.
  • 10PATRICIA C,ANNE R, ALEXIA S, et al. Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype [ J ]. Int J Cancer,2009,124 (4) :778-782.

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部